OK Biotech Co., Ltd.
OK Biotech Co., Ltd., headquartered in Taiwan (TW), is a prominent player in the biotechnology industry, specialising in innovative solutions for healthcare and life sciences. Founded in [year], the company has established itself as a leader in the development of cutting-edge biopharmaceuticals and diagnostic products, catering to both local and international markets. With a focus on research and development, OK Biotech offers a range of unique products, including advanced therapeutics and diagnostic kits that stand out for their efficacy and reliability. The company has achieved significant milestones, positioning itself as a trusted name in the biotech sector, known for its commitment to quality and innovation. Through its strategic operations across major regions, OK Biotech continues to contribute to advancements in biotechnology, enhancing patient care and outcomes globally.
DitchCarbon Score
How does OK Biotech Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OK Biotech Co., Ltd.'s score of 40 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OK Biotech Co., Ltd.'s reported carbon emissions
In 2023, OK Biotech Co., Ltd. reported total carbon emissions of approximately 41,744,000 kg CO2e for Scope 1 and 41,744,000 kg CO2e for Scope 2, alongside Scope 3 emissions of about 31,090,880 kg CO2e. This data indicates a comprehensive approach to emissions tracking across all three scopes, with significant contributions from purchased goods and services, upstream transportation, and employee commuting. The company has shown a trend in emissions over the years, with Scope 1 emissions increasing from about 17,153,420 kg CO2e in 2021 to 41,744,000 kg CO2e in 2023. Similarly, Scope 2 emissions rose from approximately 19,741,110 kg CO2e in 2021 to the same figure as Scope 1 in 2023. Scope 3 emissions also saw an increase from about 19,048,380 kg CO2e in 2021 to 31,090,880 kg CO2e in 2023. Despite these figures, there are currently no disclosed reduction targets or initiatives from OK Biotech Co., Ltd. regarding their carbon emissions. The absence of specific climate pledges or science-based targets suggests that the company may still be in the early stages of formalising its climate commitments. As the industry increasingly prioritises sustainability, it will be crucial for OK Biotech to establish clear reduction goals to align with global climate efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 17,153,420 | 00,000,000 | 00,000,000 |
| Scope 2 | 19,741,110 | 00,000,000 | 00,000,000 |
| Scope 3 | 19,048,380 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OK Biotech Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
